Germany health insurance medical treatment expenditure
Germany health insurance medical treatment expenditure stood at 14,920.88 EUR million in Q1 2026, according to Deutsche Bundesbank. It is one of the indicators in the Government finances (quarterly) table (Value · Quarterly), with a complete series running from Q1 2000 to Q1 2026. The complete series with an interactive chart, free to download.
This indicator in the Government finances (quarterly) table
| Indicator | Q1-2026 | Q4-2025 | Q3-2025 | Q2-2025 | Q1-2025 | Q4-2024 | Q3-2024 | Q2-2024 | Q1-2024 | Q4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scheme, expenditure, total | 93,201.03 | 90,638.41 | 88,016.97 | 87,514.58 | 86,490.03 | 84,126.56 | 81,579.28 | 82,224.16 | 80,253.23 | 78,859.89 | |
| Scheme, expenditure, medical treatment | 14,920.88 | 14,155.06 | 13,852.72 | 14,052.55 | 13,939.08 | 13,175.08 | 12,953.89 | 12,945.02 | 13,042.14 | 12,414.67 | |
| Scheme, expenditure, dental treatment | 5,016.65 | 4,892.58 | 4,626.58 | 4,777.31 | 4,783.66 | 4,580.36 | 4,461.8 | 4,590.8 | 4,602.57 | 4,440.38 |
Understanding germany health insurance medical treatment expenditure
Reimbursements directed toward the vast network of registered outpatient physicians map the primary clinical interface between patients and the statutory system. This flow of funds compensates general practitioners, specialists, and psychotherapists operating outside of hospital wards for consultations, diagnostics, and minor procedures. It stands entirely apart from inpatient clinical flows and pharmaceutical procurement, serving as the purest metric for everyday ambulatory care demand. The structure captures collective remuneration agreements negotiated regionally, effectively translating millions of individual doctor visits into aggregated quarterly financial settlements.
The analytical approach to this time series must prioritize year-on-year comparisons to neutralize the profound impact of seasonal viral waves and variations in the number of working days per quarter. Initial data releases are frequently subject to meaningful adjustments, as complex quarterly billing cycles between physician associations and insurance funds face significant processing lags. Shifts in the catalog of billable services or the introduction of new tele-health billing codes can engineer artificial breaks in the historical continuity. Comparing these outlays with raw patient encounter volumes often reveals a disconnect, driven by negotiated budget caps that alter reimbursement rates once regional service ceilings are breached.
Frequently asked questions
- How do individual doctors submit claims that end up in this total?
- Physicians bill their regional associations, which then settle aggregate quarterly budgets with the insurance carriers to generate these figures.
- Are private out-of-pocket payments for premium services included?
- Non-statutory extra services billed directly to patients bypass the public insurance accounts entirely.
- Do budget ceilings limit the expansion of this expenditure category?
- Negotiated regional morbidity budgets can artificially cap these outflows, meaning demand variations might dilute per-treatment payments rather than continuously move the total series.